We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
+2.56%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$23B
AUM Growth
+$654M
Cap. Flow
+$6.71M
Cap. Flow %
0.03%
Top 10 Hldgs %
15.45%
Holding
1,532
New
151
Increased
540
Reduced
484
Closed
141

Top Buys

Rank Stock Value
1
VZ icon
Verizon
VZ
+$284M
2
DB icon
Deutsche Bank
DB
+$159M
3
NSC icon
Norfolk Southern
NSC
+$108M
4
HPQ icon
HP
HPQ
+$92.2M
5
DD
Du Pont De Nemours E I
DD
+$80.9M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$161M
2
F icon
Ford
F
+$87.9M
3
WHR icon
Whirlpool
WHR
+$74M
4
PNC icon
PNC Financial Services
PNC
+$72.9M
5
EMN icon
Eastman Chemical
EMN
+$72.9M

Sector Composition

Rank Sector Weight
1 Healthcare 15.62%
2 Technology 14.22%
3 Financials 13.17%
4 Industrials 11.49%
5 Energy 8.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HYG icon
501
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.1B
$5.19M 0.02%
54,940
+20,820
+61% +$1.95M
CB icon
502
Chubb
CB
$132B
$5.18M 0.02%
52,265
+2,601
+5% +$252K
ENS icon
503
EnerSys
ENS
$6.15B
$5.17M 0.02%
74,583
+49,800
+201% +$3.49M
PXD
504
DELISTED
Pioneer Natural Resource Co.
PXD
$5.13M 0.02%
27,435
+5,703
+26% +$1.04M
IEX icon
505
IDEX
IEX
$16.4B
$5.01M 0.02%
68,740
+9,984
+17% +$727K
LMT icon
506
Lockheed Martin
LMT
$123B
$4.98M 0.02%
30,510
+3,000
+11% +$471K
MNTA
507
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$4.98M 0.02%
427,315
+29,879
+8% +$506K
ANAC
508
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
$4.97M 0.02%
248,338
+80,166
+48% +$1.55M
MXIM
509
DELISTED
Maxim Integrated Products
MXIM
$4.97M 0.02%
150,000
NBIX icon
510
Neurocrine Biosciences
NBIX
$15.2B
$4.95M 0.02%
307,468
-31,813
-9% -$544K
SYY icon
511
Sysco
SYY
$38.1B
$4.95M 0.02%
136,930
-1,600
-1% -$57.5K
FXI icon
512
iShares China Large-Cap ETF
FXI
$4.1B
$4.93M 0.02%
137,790
+11,270
+9% +$395K
MAT icon
513
Mattel
MAT
$3.83B
$4.9M 0.02%
122,267
-15,488
-11% -$615K
BNY
514
Bank of New York Mellon
BNY
$105B
$4.88M 0.02%
138,154
+37,254
+37% +$1.23M
MS icon
515
Morgan Stanley
MS
$324B
$4.87M 0.02%
156,168
+7,168
+5% +$221K
EWQ icon
516
iShares MSCI France ETF
EWQ
$345M
$4.84M 0.02%
165,867
MSI icon
517
Motorola Solutions
MSI
$77.6B
$4.84M 0.02%
+75,300
New +$4.92M
IPG
518
DELISTED
Interpublic Group of Companies
IPG
$4.82M 0.02%
281,200
-1,809,010
-87% -$30.9M
CWB icon
519
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.5B
$4.79M 0.02%
99,000
+13,930
+16% +$670K
IQV icon
520
IQVIA
IQV
$44.4B
$4.75M 0.02%
93,463
+1,087
+1% +$54.8K
HSY icon
521
Hershey
HSY
$34.2B
$4.73M 0.02%
45,272
-684,661
-94% -$70M
KLAC icon
522
KLA
KLAC
$220B
$4.71M 0.02%
682,000
-391,000
-36% -$2.53M
BVN icon
523
Compañía de Minas Buenaventura
BVN
$8.44B
$4.71M 0.02%
374,844
-17,100
-4% -$214K
FANG icon
524
Diamondback Energy
FANG
$59.2B
$4.71M 0.02%
70,000
+10,000
+17% +$575K
SWFT
525
DELISTED
Swift Transportation Company
SWFT
$4.71M 0.02%
190,200
-324,700
-63% -$7.52M

Similar funds

Axa's Q1 2014 Portfolio in Review

As of Q1 2014, Axa held 1,532 positions worth $23B, up 2.9% from $22.3B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Axa's Q1 2014 filing shows 151 new, 540 increased, 484 reduced and 141 closed positions. Its largest new stake was Celanese: 949,936 shares worth $52.7M. The largest sale was Eli Lilly, an estimated $161M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 16% a quarter earlier, followed by Technology and Financials.

  • Axa's largest Q1 2014 buy was Celanese: 949,936 shares worth $52.7M.
  • Axa added most to Verizon in Q1 2014, an estimated $284M increase.
  • Axa's biggest Q1 2014 reduction was Eli Lilly, cutting an estimated $161M.
  • Axa fully exited Avon Products, Inc. in Q1 2014, selling an estimated $53.7M.
  • Axa's ten largest holdings make up 15% of its $23B portfolio in Q1 2014.
  • Axa opened 151 new positions and closed 141 in Q1 2014.
  • Axa's portfolio value rose 2.9% quarter-over-quarter to $23B.

Based on Axa's 13F filing for Q1 2014, filed 13 May 2014.